pharmaphorum

pharmaphorum has established itself as one of the pharmaceutical industry's most widely read independent media and intelligence platforms, connecting senior professionals across drug development, commercialisation, digital health, and market access.

Founded in 2009, the platform publishes editorial content, expert commentary, and in-depth analysis aimed at pharma business strategy decision-makers rather than clinical or scientific audiences. Its coverage spans the full product lifecycle, from early pipeline considerations through to launch strategy, patient engagement, and post-market commercial performance.

The site operates a network of specialist content channels, including Deep Dive reports, sponsored content partnerships, webinars, and podcasts, giving it reach across both editorial and branded communications. Its audience is predominantly drawn from pharmaceutical companies, biotechs, consultancies, and service providers operating in Europe and North America, with a readership that includes C-suite executives, heads of market access, and commercial leaders.

pharmaphorum also functions as a thought leadership publishing partner for organisations seeking to reach senior pharma audiences, offering content marketing, white papers, and virtual events alongside its independent journalism. This dual model, editorial credibility combined with B2B content services, positions it distinctly within the life sciences media landscape.

Further information is available at pharmaphorum.com.